On ECHEMI
Home > Drugs > Glaucoma secondary to aphakia and pseudophakia
Glaucoma secondary to aphakia and pseudophakia
The incidence of secondary glaucoma after cataract surgery varies greatly with the change of surgical years, which is related to the improvement of eye microsurgery techniques. Generally speaking, the incidence of increased intraocular pressure and glaucoma after cataract surgery is less in phacoemulsification surgery than in extracapsular extraction surgery, which is less in extracapsular extraction surgery than in intracapsular extraction surgery, less in intraocular lens implantation in the capsular bag than in the ciliary sulcus, and less in posterior chamber intraocular lenses than in anterior chamber and iris intraocular lenses. In recent years, cataract extraction and intraocular lens implantation have developed rapidly, especially the improvement of sutureless surgical incisions, intraocular lens implantation in the capsular bag, the development and application of various viscoelastics, the improved design of new intraocular lenses, and the promotion of phakic emulsification. The incidence of postoperative intraocular pressure increase and glaucoma in aphakic and intraocular lens eyes has gradually decreased. However, at the same time, the surgery of complex cases has also brought some new problems, such as intraocular lens suspension surgery, intraocular lens implantation with iris diaphragm, and intraocular contact lens implantation in phakic eyes. If the intraocular pressure continues to rise, it will cause irreversible damage to the visual function. As a popular cataract restoration surgery, it is particularly important to understand and recognize the postoperative intraocular pressure increase and glaucoma, and to deal with them in a timely and appropriate manner.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Eye pain high intraocular pressure lens displacement lens iron deposition lens expansion and enlargement
  • Concurrent disease:

Related Drugs
Mingmu Dihuang Pills
Manufacturer:

Hebei Bianque Pharmaceutical Co., Ltd.

Mingmu Dihuang Pills
Manufacturer:

Hebei Bianque Pharmaceutical Co., Ltd.

Methazolamide Tablets
Indication: It is used as an adjuvant treatment for patients with primary open-angle glaucoma, angle-closure glaucoma and some secondary glaucoma whose intraocular pressure is not well controlled by topical anti-glaucoma drugs. Because this product has less effect on acid-base balance while lowering intraocular pressure, it is better than acetazolamide for patients with severe obstructive pulmonary disease. Methazolamide has less effect on urinary citrate secretion than acetazolamide, so it is recommended for patients who need oral carbonic anhydrase inhibitor treatment but are prone to kidney stone formation.
Manufacturer:

Hangzhou Qianyuan Baoling Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.